Sort   by:  
 Page size 
UnknownA rapid review of the impact of COVID-19 on the mental health of healthcare workers: implications for supporting psychological well-being.
Not available
S-EPMC7794640 | biostudies-literature
TranscriptomicsGenetics of gene expression in primary immune cells
Gene expression arrays and genotyping data in primary human immune cells from healthy European 288 individuals.
ORGANISM(S): Homo sapiens 
2012-03-01 | E-MTAB-945 | biostudies-arrayexpress
UnknownEffect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial.
Not available
S-EPMC11798631 | biostudies-literature
UnknownThe Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction.
Not available
S-EPMC11096866 | biostudies-literature
UnknownAssociation of preoperative anaemia with cardiopulmonary exercise capacity and postoperative outcomes in noncardiac surgery: a substudy of the Measurement of Exercise Tolerance before Surgery (METS) Study.
Not available
S-EPMC6676367 | biostudies-literature
UnknownImproving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry.
Not available
S-EPMC9549605 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownCystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study.
Not available
S-EPMC10807905 | biostudies-literature
UnknownIntermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Not available
S-EPMC3159416 | biostudies-literature
UnknownAddition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Not available
S-EPMC3159415 | biostudies-literature
Sort   by:  
 Page size